These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2331044)

  • 21. The effect of cyclosporine in chlamydial eye infection.
    Young E; Schachter J; Prendergast RA; Taylor HR
    Curr Eye Res; 1987 May; 6(5):683-9. PubMed ID: 3595180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective.
    Bailey RL; Kajbaf M; Whittle HC; Ward ME; Mabey DC
    Epidemiol Infect; 1993 Oct; 111(2):315-24. PubMed ID: 8405158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of Chlamydia trachomatis infection and the requirements for a vaccine.
    Schachter J
    Rev Infect Dis; 1985; 7(6):713-6. PubMed ID: 3840910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis.
    Porcella SF; Carlson JH; Sturdevant DE; Sturdevant GL; Kanakabandi K; Virtaneva K; Wilder H; Whitmire WM; Song L; Caldwell HD
    Infect Immun; 2015 Feb; 83(2):534-43. PubMed ID: 25404022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia-specific lymphocytes in conjunctiva during ocular infection: limiting dilution analysis.
    Pal S; Pu Z; Huneke RB; Taylor HR; Whittum-Hudson JA
    Reg Immunol; 1990-1991; 3(4):171-6. PubMed ID: 1716948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An animal model for cicatrizing trachoma.
    Taylor HR; Prendergast RA; Dawson CR; Schachter J; Silverstein AM
    Invest Ophthalmol Vis Sci; 1981 Sep; 21(3):422-33. PubMed ID: 7275529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the humoral immune response in trachoma to Chlamydia trachomatis major outer membrane proteins by sequence-defined immunoassay.
    Jones HM; Schachter J; Stephens RS
    J Infect Dis; 1992 Oct; 166(4):915-9. PubMed ID: 1527430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation outside variable segments of the major outer membrane protein distinguishes trachoma from urogenital isolates of the same serovar of Chlamydia trachomatis.
    Frost EH; Deslandes S; Gendron D; Bourgaux-Ramoisy D; Bourgaux P
    Genitourin Med; 1995 Feb; 71(1):18-23. PubMed ID: 7538486
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interpretation of Chlamydia trachomatis antibody response in chlamydial oculogenital infection.
    Patel HC; Goh BT; Viswalingam ND; Treharne JD
    Genitourin Med; 1995 Apr; 71(2):94-7. PubMed ID: 7744422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An animal model of trachoma II. The importance of repeated reinfection.
    Taylor HR; Johnson SL; Prendergast RA; Schachter J; Dawson CR; Silverstein AM
    Invest Ophthalmol Vis Sci; 1982 Oct; 23(4):507-15. PubMed ID: 6749750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infection with Chlamydia trachomatis immunotype J associated with trachoma in children in an area previously endemic for trachoma.
    Harrison HR; Boyce WT; Wang SP; Gibb GN; Cox JE; Alexander ER
    J Infect Dis; 1985 Jun; 151(6):1034-6. PubMed ID: 3998505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a safe and effective chlamydial vaccine: lessons from the eye.
    Mabey DC; Hu V; Bailey RL; Burton MJ; Holland MJ
    Vaccine; 2014 Mar; 32(14):1572-8. PubMed ID: 24606636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The owl monkey (Aotus trivirgatus) as an animal model in trachoma research.
    Fraser CE
    Lab Anim Sci; 1976 Dec; 26(6 Pt 2):1138-41. PubMed ID: 828229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
    Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
    BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains.
    Carlson JH; Porcella SF; McClarty G; Caldwell HD
    Infect Immun; 2005 Oct; 73(10):6407-18. PubMed ID: 16177312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An animal model of trachoma: IV. The failure of local immunosuppression to reveal inapparent infection.
    Taylor HR; Johnson SL; Schachter J; Prendergast RA
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):647-50. PubMed ID: 6841015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term clinical, microbiological, and immunological observations of a volunteer repeatedly infected with Chlamydia trachomatis.
    Hanna L; Jawetz E; Dawson CR; Thygeson P
    J Clin Microbiol; 1982 Nov; 16(5):895-900. PubMed ID: 7153340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune mechanisms in chlamydial eye infection: cellular immune responses in chronic and acute disease.
    Young E; Taylor HR
    J Infect Dis; 1984 Nov; 150(5):745-51. PubMed ID: 6238106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survey, Culture, and Genome Analysis of Ocular
    Feng L; Lu X; Yu Y; Wang T; Luo S; Sun Z; Duan Q; Wang N; Song L
    Front Cell Infect Microbiol; 2016; 6():207. PubMed ID: 28119858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.